Lab Tests Take Flight
By CLN Stat Posted on 29 Jul 2019 |
(Photo courtesy of AACC)
A North Carolina medical facility has teamed up with national aviation, technology, and delivery service leaders to take part in the first medical drone delivery operation over a densely populated area of the United States, with a goal of improving patient care by speeding deliveries at a lower cost and expediting life-saving treatments.
Unmanned aviation drones deliver 10 times faster than ground transport, according to UPS, which has partnered with WakeMed Health & Hospitals in Raleigh, North Carolina, drone technology company Matternet, the Federal Aviation Administration (FAA), and North Carolina Department of Transportation (NCDOT) on this project. Since March, routine revenue flights have been taking place on the WakeMed campus under FAA and NCDOT oversight. Routine lab samples, which may include complete blood count and blood chemistry tests, liver function tests or cholesterol tests, travel by Matternet’s M2 Drone quadcopter from WakeMed Raleigh Medical Park’s outpatient clinic to WakeMed Raleigh Campus, its flagship hospital and site of the central pathology lab. Medical professionals load the sample encased in a secure container into the drone, and a remote pilot-in-command keeps track of each flight and troubleshoots any problems that arise.
Each drone is equipped with a parachute and other features to protect the samples in case of an emergency. However, the operators will either limit or pause drone flight in instances of high winds, ice, or rain.
Drone technology has the potential to transform health and healthcare delivery, Stuart Ginn, MD, WakeMed otolaryngologist and medical director for WakeMed Innovations, told CLN Stat. First-round test flights took place at WakeMed last summer, part of FAA’s 3-year Unmanned Aircraft System (UAS) Integration Pilot Program (IPP), which partners local governments with private sector companies to further investigate the commercial applications of drone technology.
“Our team has been working on UAS medical package delivery solutions for more than two years. We were thrilled when the FAA’s IPP was announced,” Ginn said. The application from WakeMed and its partners was one of 10 the FAA selected from a nationwide pool.
August 29, 2018, marked IPP’s first U.S. medical drone delivery test flight at WakeMed, in partnership with NCDOT’s Division of Aviation and Matternet. Following more than 100 test flights, UPS in March announced a new logistics service to deliver medical samples via unmanned drones. “This announcement, and the drone that took flight at WakeMed on March 26, was the next major milestone for unmanned aviation in the U.S., as it marked the first FAA-sanctioned use of a drone for routine revenue flights involving the transport of a product under a contractual delivery agreement,” explained Ginn.
Creating efficiencies in transporting routine blood and urine specimens is the initiative’s current focus. Courier vehicles will continue to transport items such as tissue samples from biopsies and pharmaceuticals although the partners are evaluating opportunities to move other items by UAS, such as pharmaceuticals, as the project expands. The ultimate goal is to build a network of UAS routes connecting all of the freestanding hospitals and healthplexes across the WakeMed system, according to Ginn. Next steps are to implement a UAS route connecting WakeMed’s Garner Healthplex to the WakeMed Raleigh Campus.
“The ability to work directly with regulators and technology leaders has allowed us to make tremendous progress,” Ginn said. “We’re proud to lead the way in developing this expertise for other healthcare systems who will use this technology in the future.”
Matternet may soon face some competition from other drone companies in the commercial space. Just recently, Wing, a subsidiary of Google parent Alphabet Inc. received FAA air carrier certification to deliver small commercial packages and has launched services in Virginia, with plans to expand. According to one news report, delivery items may include over-the-counter medications. The University of Maryland Medical Center (UMMC) in Baltimore also just announced that a drone flight had been used to deliver a kidney for transplant at UMMC.
Related Links:
AACC
Unmanned aviation drones deliver 10 times faster than ground transport, according to UPS, which has partnered with WakeMed Health & Hospitals in Raleigh, North Carolina, drone technology company Matternet, the Federal Aviation Administration (FAA), and North Carolina Department of Transportation (NCDOT) on this project. Since March, routine revenue flights have been taking place on the WakeMed campus under FAA and NCDOT oversight. Routine lab samples, which may include complete blood count and blood chemistry tests, liver function tests or cholesterol tests, travel by Matternet’s M2 Drone quadcopter from WakeMed Raleigh Medical Park’s outpatient clinic to WakeMed Raleigh Campus, its flagship hospital and site of the central pathology lab. Medical professionals load the sample encased in a secure container into the drone, and a remote pilot-in-command keeps track of each flight and troubleshoots any problems that arise.
Each drone is equipped with a parachute and other features to protect the samples in case of an emergency. However, the operators will either limit or pause drone flight in instances of high winds, ice, or rain.
Drone technology has the potential to transform health and healthcare delivery, Stuart Ginn, MD, WakeMed otolaryngologist and medical director for WakeMed Innovations, told CLN Stat. First-round test flights took place at WakeMed last summer, part of FAA’s 3-year Unmanned Aircraft System (UAS) Integration Pilot Program (IPP), which partners local governments with private sector companies to further investigate the commercial applications of drone technology.
“Our team has been working on UAS medical package delivery solutions for more than two years. We were thrilled when the FAA’s IPP was announced,” Ginn said. The application from WakeMed and its partners was one of 10 the FAA selected from a nationwide pool.
August 29, 2018, marked IPP’s first U.S. medical drone delivery test flight at WakeMed, in partnership with NCDOT’s Division of Aviation and Matternet. Following more than 100 test flights, UPS in March announced a new logistics service to deliver medical samples via unmanned drones. “This announcement, and the drone that took flight at WakeMed on March 26, was the next major milestone for unmanned aviation in the U.S., as it marked the first FAA-sanctioned use of a drone for routine revenue flights involving the transport of a product under a contractual delivery agreement,” explained Ginn.
Creating efficiencies in transporting routine blood and urine specimens is the initiative’s current focus. Courier vehicles will continue to transport items such as tissue samples from biopsies and pharmaceuticals although the partners are evaluating opportunities to move other items by UAS, such as pharmaceuticals, as the project expands. The ultimate goal is to build a network of UAS routes connecting all of the freestanding hospitals and healthplexes across the WakeMed system, according to Ginn. Next steps are to implement a UAS route connecting WakeMed’s Garner Healthplex to the WakeMed Raleigh Campus.
“The ability to work directly with regulators and technology leaders has allowed us to make tremendous progress,” Ginn said. “We’re proud to lead the way in developing this expertise for other healthcare systems who will use this technology in the future.”
Matternet may soon face some competition from other drone companies in the commercial space. Just recently, Wing, a subsidiary of Google parent Alphabet Inc. received FAA air carrier certification to deliver small commercial packages and has launched services in Virginia, with plans to expand. According to one news report, delivery items may include over-the-counter medications. The University of Maryland Medical Center (UMMC) in Baltimore also just announced that a drone flight had been used to deliver a kidney for transplant at UMMC.
Related Links:
AACC
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Better Predicts Heart Disease Risk
Cardiovascular diseases (CVDs) are the primary cause of death worldwide. A large proportion of these cases could be prevented by addressing lifestyle and environmental factors such as smoking, poor diet,... Read more
New Blood Test Detects 12 Common Cancers Before Symptoms Appear
Bowel cancer is the fourth most common cancer in the UK, with over 42,000 new diagnoses each year. Detecting bowel cancer in its early stages can be challenging, and as the disease progresses, survival... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more